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Abstract A wild-type human procathepsin B was expressed, 
crystallized in two crystal° forms and its crystal structure 
determined at 3.2 and 3.3 A resolution. The structure reveals 
that the propeptide folds on the cathepsin B surface, shielding the 
enzyme active site from exposure to solvent. The structure of the 
enzymaticaily active domains is virtually identical to that of the 
native enzyme [Musil et al. (1991) EMBO J. 10, 2321-2330]: the 
main difference is that the occluding loop residues are lifted 
above the body of the mature enzyme, supporting the propeptide 
structure. 
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1. Introduction 
The lysosomal cysteine proteases, cathepsins B, H, L, S and 
C, are well characterized proteins with closely related amino 
acid sequences, belonging to the papain superfamily [1]. They 
have been implicated in many normal cellular processes uch 
as protein degradation and turnover [2], antigen presentation 
[3,4], bone remodeling [5] and prohormone processing [6]. The 
two most extensively studied cysteine proteases, cathepsin B 
and cathepsin L, appear to be involved in a variety of disease 
states such as rheumatoid arthritis [7], Alzheimer's disease [8], 
tumor invasiveness [9] and osteoporosis [10]. 
Lysosomal enzymes are synthesized in normal cellular pro- 
cesses as glycosylated higher molecular weight precursors, 
which, during their maturation, undergo several processing 
steps by limited proteolysis [2]. Cathepsin B maturation in- 
cludes removal of the N-terminal propeptide, the C-terminal 
extension and a dipeptide between residues 47 and 50 (mature 
enzyme numbering). The product is an enzymatically active 
molecule with two chains covalently cross-linked by a disul- 
fide bridge [11,12]. 
The crystal structures of human and rat cathepsin B [13,14] 
have confirmed high structural similarity to plant enzyme pa- 
pain [16] and structural reasons for cathepsin B peptidyl di- 
peptidase activity [13,15] have also been revealed. An under- 
standing of the molecular basis for the activation mechanism 
[17 19] of cathepsin B requires knowledge of the 3-dimen- 
sional structure of the proenzyme. Crystal structures of sev- 
eral serine, aspartic and zinc proteases and their zymogens 
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provided clues necessary for understanding of the structural 
bases of their activation mechanisms ([20-23]; only some pa- 
pers are referenced here). The 3-dimensional structure of the 
human cathepsin B proenzyme reported here now sheds light 
on an as yet unresolved interaction between a cysteine pro- 
tease and its propeptide. 
2. Materials and methods 
Recombinant human procathepsin B was expressed in E. coli in the 
form of inclusion bodies as described by Kuhelj et al. [24]. After 
folding, the protein was concentrated by a Centricon 10 concentrator 
(Amicon) to a concentration of 15 mg/ml. When compared to the 
procathepsin B cDNA sequence [11], the protein expressed possessed 
an amino acid substitution i  the pro-part (VaI-P9 to Leu), probably 
due to polymorphism [24]. The protein was expressed with an addi- 
tional Met on the N-terminus and without he C-terminal hexapeptide 
extension. Two crystal forms were obtained in sitting drops at 20°C 
using the vapor diffusion technique. Hexagonal crystals (dimensions 
0.3 ×0.1 ×0.1 mm 3) were grown from 2 M ammonium sulphate, 700 
mM Tris-HC1 pH 7.1. They belong to space group P6~22 and have 
one molecule per asymmetric unit. Orthorhombic crystals (dimensions 
0.2x0.1 x0.1 mm a) were grown from 30% PEG 6000, 0.2 M ammo- 
nium sulphate, 0.1 M HEPES-NaOH, pH 7.3. They belong to space 
group P212121 with one molecule per asymmetric unit. Diffraction 
data up to 3.3 ~, resolution for hexagonal crystals and 3.2 A for 
the orthorhombic ones were collected on an MAR imaging plate 
system using a Rigaku rotation anode with copper radiation as the 
X-ray source. All diffraction data were processed using the MOSFLM 
[25] and CCP4 package [26]. The completeness of data is 94.2% in the 
resolution range of 10.0 3.3 A for the hexagonal crystal form and 
88.5% in the resolution range of 10.0-3.2 A for the orthorhombic 
crystal form. 
The orientation and position of the procathepsin B molecules in 
both crystal forms were found with the help of the AMoRe suite of 
programs [27]. Human native cathepsin B structure [13] was used for 
the starting search model. The rotation and translation functions were 
computed using data between 15 and 4 .~ resolution, and gave R 
values of 0.416 and 0.420 for the hexagonal nd orthorhombic crystal 
forms, respectively. 
Henceforth, the program MAIN running on an Silicon Graphics 
Indigo 2 [28] was used interactively for electron density map calcula- 
tions, model building, structure refinement and electron density aver- 
aging procedures unless explicitly specified otherwise. The parameter 
set of Engh and Huber [29] was used throughout the model building 
and structure refinement procedures. 
Visual inspection of the first electron density map showed clear 
electron density for the search model cathepsin B and revealed some 
regions where the propeptide chain was bound. It was also evident 
that the cathepsin B occluding loop residues (106-124) did no have 
adequate lectron density. A model with occluding loop residues 
omitted was then crystallographically refined and the resulting map 
used for building segments of propeptide chain as a polyalanine mod- 
el. 
When the orthorhombic crystal form data became available, the 
electron density between the two crystal forms was averaged in several 
cycles. The molecular model was built and crystallographically refined 
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in both crystal forms simultaneously. Besides the usually applied en- 
ergy terms, we also used non-crystallographic symmetry constraints 
between the models of the two crystal forms. These enabled us to 
obtain the unbroken density of the whole proenzyme chain, including 
the occluding loop in the orthorhombic form, and allowed us to 
complete the model building. Parts of the chain in the hexagonal 
form, however, were still not visible. The resulting crystallographic 
R values were 0.255 for orthorhombic and 0.265 for hexagonal 
data. Subsequent molecular dynamics procedures (at 500 K for 3000 
steps) followed by annealing using X-PLOR [30] of the two crystal 
forms models brought he R values down to 0.229 and 0.230 for the 
orthorhombic and hexagonal crystal forms, respectively. After the 
models from both crystal forms were superimposed, it became vident 
that the annealing procedure kept most parts of the structures close to 
each other, only the propeptide r sidues in the region from Gly-P47 to 
Lys-P62 being significantly displaced (up to 2.0 A). The overlap of 
superimposed lectron density maps in this region became worse and 
further minimization attempts with MAIN to enforce similarity in the 
region by applying noncrystallographic symmetry constraints only 
raised the R value. We concluded therefore that the differences be- 
tween the two crystal forms in this part of the propeptide chain are 
real. 
The crystallographic R values of the final models are 0.2158 (5051 
unique reflections in resolution range between 10.0 and 3.2 A) and 
0.2313 (4011 unique reflections in the resolution range between 10.0 
and 3.3 A) for the orthorhombic and hexagonal model, respectively. 
The backbone conformation of all residues is within the Ramachan- 
dran plot limits. The RMS deviations from target values are 0.0114 
and 0.0119 ,~ for bond lengths and 1.77 and 1.83 ° for angles of the 
crystallographically weighted atoms for the orthorhombic and hexa- 
gonal models, respectively. No individual or group atomic B value 
refinement was applied to either of the structures. 
3. Results and discussion 
The crystal structures of the single chain procathepsin B
comprise the propeptide sequence from Arg-P1 to Lys-P62 
and the cathepsin B sequence from Leu-1 to Asp-254 (Fig. 
1). The whole chain, apart from a few N-terminal residues, is 
well defined by the electron density maps of the orthorhombic 
crystal form. In addition to the N-terminal residues, the hex- 
agonal structure lacks adequate lectron density for the pro- 
peptide residues Glu-P59 and Asp-P60 and mature enzyme 
residues Asn- l l3,  Gly- l l4  and Ser-l l5 from the occluding 
loop region. The following description of the structure refers 
to the orthorhombic model. 
The structure of the procathepsin B mature enzyme do- 
mains is virtually identical to that of cathepsin B [13] (Fig. 
1). The RMS deviation between the CA atoms of mature 
enzyme structure [13] and structurally equivalent CA atoms 
of the two independently refined proenzyme structures are 
0.43 and 0.44 A for the orthorhombic and hexagonal forms, 
respectively. The mature enzyme domains contact each other 
through an extended polar interface across a large surface in 
the middle of the enzyme. The structure is reminiscent of a 
book that, when closed, brings together the active site residues 
Cys-29 and His-199 at the bottom of a 'V'-shaped active site 
cleft situated on the top of the enzyme structure. (The mature 
enzyme domains are denoted throughout the text by R-and L- 
according to their right and left position in the standard view 
used in Fig. 1.) 
The only substantial difference between the cathepsin B 
structure and the structure of enzymatic domains in the 
proenzyme is observed in the occluding loop region (residues 
between Ile-105 and Pro-126). The occluding loop in the ca- 
thepsin B structure blocks the active site cleft from the back, 
whereas in the proenzyme it is lifted away from the enzyme 
surface, building a wall that interacts extensively with the 
propeptide, thus supporting its structure (Fig. 2). 
The propeptide chain embraces the mature cathepsin B do- 
mains (see Fig. 1). The propeptide starts as a disordered chain 
that runs into a quite regularly folded region with defined 
secondary structure lements (Leu-P9 to Cys-P42). The folded 
region begins as a short extended chain followed by a e~-~ 
structural motif (three-tum a-helix and associated short anti- 
parallel I~-structure). From there the next six residues run in 
an extended conformation with a kink in the middle. From 
the kinked region the propeptide chain folds down to the 
active site as a two-turn c~-helix (Asp-P34 to Cys-P42) which 
sits on top of the active site. From there on the chain runs in 
an extended conformation towards the cathepsin B N-termi- 
nus, quite loosely packed on the enzyme surface. 
Interactions between the propeptide chain and the mature 
Fig. 1. CA plot of human procathepsin B structure superimposed on the human cathepsin B structure [13]. The proenzyme fold is shown by 
continuous lines: the propeptide chain is indicated by the bold line, the mature nzyme domains by thin lines and the active-site residues Cys- 
29 and His-199 are marked and their side chains are shown by bold lines. Proenzyme residues mentioned in the text are marked. The human 
cathepsin B structure is presented using broken lines. 
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Fig. 2. Electron density map phased by the final model and contoured at the 1.0 o level is shown for 2.3 A. around the occluding loop residues 
(only residues between Pro-106 and Cys-ll9 are seen). The occluding loop residues are drawn in bold, propeptide r sidues (in the back) with 
the line of intermediate hickness and the rest of mature cathepsin B domain is shown in thin line. 
enzyme domains exhibit hydrophobic as well and hydrophilic 
character. No disulfide bridge or salt bridges are observed in 
the interface. 
4. Propeptide folded region 
The folded region of the propeptide sits on top of the Phe- 
174- His-199 loop, the t~-~ structural motif in its middle being 
anchored with the Trp-P24 indole ring (Fig. 3). This results in 
the propeptide shielding a substantial part of the cathepsin B
hydrophobic surface from solvent. The location of the ~ part 
of the ct-I] structural motif on the top of the loop is further 
stabilized by an anti-parallel [~-strand hydrogen bond arrange- 
ment. 
The residues of the kinked region (from Asn-P29 to Asp- 
P34) interact with the cathepsin B occluding loop through a 
number of hydrogen bonds that involve main as well as side 
chain interactions. The side chains of the propeptide residues 
Tyr-P37 and Arg-P40 are squeezed between the occluding 
loop and the body of the mature enzyme. The Tyr-P37 ring 
is placed below the occluding loop disulfide bridge 108-119 
and the Arg-P40 side chain is placed beneath Glu-122. These 
residues erve to lift the occluding loop away from the rest of 
the enzyme surface. 
Removal of the propeptide thus results in substantial desta- 
bilization of the occluding loop conformation and it essen- 
tially falls down on the enzyme surface into the arrangement 
observed in the mature cathepsin B structure. The occluding 
loop of cathepsin B thus appears to be quite flexible and 
capable of adopting two quite different conformations in spite 
of an internal disulfide bridge and two pairs of sequential 
proline residues. 
We assume that the propeptide N-terminal region (includ- 
ing residues from Ser-P5 to Cys-P42), similarly to the occlud- 
ing loop, cannot keep its tertiary structure observed in the 
proenzyme after dissociation from the enzyme domain. The 
spatial arrangements of those parts with regular secondary 
structure are stabilized mostly through contacts with the sur- 
face of cathepsin B. The only exception is the tx-~l structural 
motif which is internally stabilized by two hydrogen bonds: 
' 87  
\ 
7 ).'l 
Fig. 3. Electron density map phased by the final model and contoured at the 1.0 c level is shown for 2.3 A around the tx-~ structural motif in- 
cluding residues from P9 to P42 and their surroundings. The Trp-P24 moiety is shown embedded in the middle of the hydrophobic surface of 
the cathepsin B Phe-174-His 199 loop. The propeptide main chain is drawn with the thickest lines and the side chains with lines of intermedi- 
ate thickness. Thin lines represent the bonds of the cathepsin B mature form domains. 
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The first is formed between the Asn-P18 side chain OD1 atom 
and the main chain amide hydrogen of Ala-P26 and brings 
together the last helical turn and the middle of the ~ strand. 
The second one connects the carbonyl groups of Leu-P9 and 
Ser-P10, situated before the beginning of the helix, to the 
imidazole ring of His-P28, the last residue in the ~ region. 
Thus the substantial hydrophobic surface of the propeptide 
folded region that, in the proenzyme structure, spans the ca- 
thepsin B R-domain hydrophobic surface might, in solution, 
merge into a single hydrophobic ore enclosed by the hydro- 
philic surface of the secondary structure lements which, in 
the proenzyme structure, are exposed to solvent. This reason- 
ing finds support in kinetic measurements reported by Fox 
[31], where it was shown that inhibition of cathepsin B by 
its propeptide xhibits slow binding kinetics. Thus binding 
of cathepsin B propeptide to the enzyme would appear to 
involve structural rearrangement. 
5. Propeptide linker peptide 
After leaving the folded region, the propeptide chain runs in 
an extended chain along the active site cleft across the S1 and 
$2 binding subsites (Gly-P43-Leu-P46), making a turn across 
Glu-245 at Gly-P47-Pro-P52, and then continues quite loosely 
packed along the L-and R-domain interface towards the ca- 
thepsin B N-terminal residues (Gln-P53-Lys-P62). The chain 
is slightly lifted above the cathepsin B surface, with only a 
couple of main chain interactions, and is therefore rather flex- 
ible. The flexibility is indicated by the different chain place- 
ment in the two crystal structures. Deviation between some 
equivalent atoms exceeds 2 ,~. Flexibility in this part is not 
surprising, since cleavage of peptide bonds in this region re- 
sults in cathepsin B activation [17,18]. The scissile bonds are 
exposed to solvent in the proenzyme structure and thus avail- 
able for cleavage by an approaching protease. Besides activa- 
tion with other enzymes, including mature cathepsin B, it was 
also reported that procathepsin B, when introduced into an 
acidic environment, is capable of autocatalytic processing 
[18,19,32]. The reported autocleavage scissile bond is between 
the residues Met-P56 and Phe-P57 [33]. Obviously the acidic 
environment neutralizes ome carboxylic group(s), which re- 
sults in liberation of the bound propeptide and consequent 
exposure of the active site to solvent. However, since no salt 
bridge between propeptide and mature enzyme is observed in 
the proenzyme structure the mechanism of procathepsin B
autoactivation remains to be answered. 
Acknowledgements: We gratefully acknowledge the assistance of F. 
Schneider and A. Bergner in data collection, data processing and 
initial molecular replacement with the first hexagonal data set. Profs. 
W. Bode and R. Huber are gratefully acknowledged for their perma- 
nent interest and critical discussions. Thanks for critical reading of the 
manuscript go to Prof. R. Pain. Atomic coordinates of the two struc- 
tures will be deposited in the Brookhaven Protein Data Bank. This 
work was supported by the Slovenian Ministry of Science and Tech- 
nology and the European Community Grant CHRX-CT94-0535. 
References 
[1] Berti, P.J. and Storer, A.C. (1995) J. Mol. Biol. 246, 273-283. 
[2] Bond, J.S. and Butler, P.E. (1987) Annu. Rev. Biochem. 56, 333- 
364. 
[3] Roche, P.A. and Cresswell, P. (1991) Proc. Natl. Acad. Sci. USA 
87, 1927-1933. 
[4] Morton, P.A., Zacheis, M.L., Giacoletto, K.S., Manning, J.A. 
and Schwartz, B.D. (1995) J. Immunol. 154, 137 150. 
[5] Tezuka, K., Tezuka, Y., Maejima, A., Sato, T., Nemoto, K., 
Kamioka, H., Hakeda, Y. and Kumegawa, M. (1994) J. Biol. 
Chem. 269, 1106-1109. 
[6] Krieger, T.J. and Hook, V.Y.H. (1991) J. Biol. Chem. 266, 8376~ 
8383. 
[7] Buttle, D.J., Saklatvala, J. and Barrett, A.J. (1993) Agents Action 
Suppl. 39, 161-165. 
[8] Pentaceska, S., Burke, S., Watson, S.J. and Devi, L. (1994) Neu- 
roscience 59, 729-738. 
[9] Sloane, B.F., Moin, K. and Lah, T.T. (1994) in: Biochem. Mol. 
Aspects Select. Cancers, vol. 2 (Pretlow, T.G. and Pretlow, T.P. 
eds.) pp. 411460, Academic Press, San Diego. 
[10] Delaisse, J.M., Pascale, L. and Vaes, G. (1991) Biochem. J. 279, 
167-174. 
[11] Chan, S.J., San Segundo, B., McCormick, M.B. and Steiner, 
D.F. (1986) Proc. Natl. Acad. Sci. USA 83, 7721-7725. 
[12] Takio, K., Towatari, T., Katunuma, N., Teller, D.C. and Titani, 
K. (1983) Proc. Natl. Acad. Sci. USA 80, 3666-3670. 
[13] Musil, D., Zu6i~, D., Turk, D., Engh, R.A., Mayr, I., Huber, R., 
Popovi6, T., Turk, V., Towatari, T., Katunuma, N. and Bode, 
W. (1991) EMBO J. 10, 2321~330. 
[14] Jia, Z., Hasnain, S., Hirmama, T., Lee, X., Mort, J.S., To, R. 
and Huber, C.P. (1995) J. Biol. Chem. 270, 5627-5633. 
[15] Turk, D., Podobnik, M., Popovi6, T., Katunuma, N., Bode, W., 
Huber, R. and Turk, V. (1995) Biochemistry 34, 47914797. 
[16] Drenth, I., Jansonius, J.N., Koekoek, R., Swen, H.M. and 
Wolthers, B.G. (1968) Nature 249, 54-57. 
[17] Rowan, A.D., Mason, P., Mach, L. and Mort, J.S. (1992) J. Biol. 
Chem. 267, 15993-15999. 
[18] Mach, L., Stfiwe, K., Hagen, A., Ballaun, C. and G16ssl, J. 
(1992) Biochem. J. 282, 577-582. 
[19] Mach, L., Schwihla, H., Sfiiwe, K., Rowan, A.D., Mort, J.S. and 
G16ssl, J. (1993) Biochem. J. 293, 437442. 
[20] Huber, R. and Bode, W. (1978) Acc. Chem. Res. 11, 114-122. 
[21] James, M.N.G. and Sielecki, A.R. (1986) Nature 319, 33-38. 
[22] Coil, M., Guasch, A., Aviles, F.X. and Huber, R. (1991) EMBO 
J. 10, 1-9. 
[23] Bryan, P., Wang, L., Hoskins, J., Ruvinov, S., Strausberg, S., 
Alexander, P., Almog, O., Gilliland, G. and Gallagher, T. 
(1995) Biochemistry 34, 1031(~10318. 
[24] Kuhelj, R., Dolinar, M., Punger6ar, J. and Turk, V. (1995) Eur. 
J. Biochem. 229, 533 539. 
[25] Leslie, A.G.W. (1994) Mosflm Users Guide, Mosflm version 5.23, 
MRC Laboratory of Molecular Biology, Cambridge, UK. 
[26] CCP4 (1994) Acta Crystallogr. D50, 760-763. 
[27] Navaza, J. (1994) Acta Crystallogr. A50, 157-163. 
[28] Turk, D. (1992) Doctoral Thesis Technische Universit~it Mfin- 
chen. 
[29] Engh, R.A. and Huber, R. (1991) Acta Crystallogr. A47, 392- 
400. 
[30] Brfinger, A.T. (1992) X-PLOR, Version 3.1, A System for X-ray 
Crystallography and NMR, Yale University Press, New Haven, 
CT. 
[31] Fox, T., De Miguel, E., Mort, J.S. and Storer, A.C. (1992) Bio- 
chemistry 31, 12571-12576. 
[32] Mach, L., Mort, J.S. and G16ssl, J. (1994) Maturation of human 
procathepsin B. J. Biol. Chem. 269, 13030-13035. 
[33] Mach, L., Mort, J.S. and G16ssl, J. (1994) J. Biol. Chem. 269, 
1303(~13040. 
